| FIX |
Report |
Revenue |
BEAT |
pred ~$3.10B vs. cons $2.96B |
HIGH |
| FIX |
Report |
Diluted EPS |
BEAT |
pred ~$11.30 vs. cons $10.40 |
HIGH |
| FIX |
Report |
Backlog (quarter-end) |
BEAT |
pred ~$13.2B vs. cons $12.5B (prior record) |
MEDIUM |
| FIX |
Guide |
FY26 same-store revenue growth |
BETTER |
guide ~high-20s% vs. cons ~mid-20s% (FY26) |
MEDIUM |
| FIX |
Guide |
Gross margin (core, ex one-time) |
BETTER |
guide ~25.5% vs. cons ~24.5% (Q2/2H26) |
MEDIUM |
| FIX |
Guide |
Book-to-bill / bookings cadence |
UNKNOWN |
guide ~1.1-1.2x vs. cons ~1.0x (Q2/FY26) |
LOW |
| FIX |
Return |
Day-1 residual (stock − beta × S&P 500) |
+5.0% |
— |
MEDIUM |
| FIX |
Return |
5-day cumulative residual |
+6.5% (FOLLOW-THROUGH) |
A clean EPS/revenue beat plus a fresh record backlog and a raised/refined FY26 same-store guide should drive positive estimate revisions; the AI/data-center momentum bid and net-cash balance sheet support follow-through despite ~35x forward multiple. Main risk to fade: lapping the Q1 $43M one-time margin item and tougher H2 comps could cap out-period estimate raises, so upside is momentum-driven rather than a large multiple re-rate — hence follow-through but not a runaway move. High beta (~2.6) makes the residual noisy. |
LOW |